When will Covid19 Vaccines be made ready to Indian Citizens?
PM modi said the roadmap for the production of coronavirus vaccines and its fair distribution in the country is ready. PM narendra modi said that three vaccines, that are being developed and tested in india to fight the novel coronavirus, are at different stages of testing. PM narendra modi also said his government will ensure every indian gets vaccinated against coronavirus. He said the mass production of coronavirus vaccine will begin once scientists give their nod. PM modi said, "Three coronavirus vaccines are at different testing stages in India. The roadmap for its production and distribution among the indians is also ready. The government will ensure every indian gets the vaccine against coronavirus."
PM modi said "As soon as the scientists give a green signal, the country will begin their large-scale production," PM narendra modi said, adding the talent of "our scientists is like that of rishi munis. We will announce the roadmap for its distribution as soon as it gets final clearances". Moreover PM modi said the government would soon announce the National wallet PLATFORM' target='_blank' title='digital-Latest Updates, Photos, Videos are a click away, CLICK NOW'>digital health Mission under which, every citizen would get a health ID. "National wallet PLATFORM' target='_blank' title='digital-Latest Updates, Photos, Videos are a click away, CLICK NOW'>digital health Mission will bring a new revolution in India's health sector," PM modi said, adding, "Health updates will be logged in the health ID on every visit to a pharmacy or a doctor." Every indian will have his own health ID. This ID will have all details like disease, treatment, doctors, hospital visits, payment details, medicine he/she using," PM modi said.
The phase-1 and 2 human clinical trials of two of them, developed indigenously by Bharat Biotech, in collaboration with the indian Council of Medical Research (ICMR), and Zydus Cadila Ltd, are currently underway and also the Serum Institute of india has been permitted for conducting Phase 2 and 3 human clinical trials of the third vaccine candidate developed by Oxford University.